iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
DEL PRIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionWilliams Jones Wealth Management, LLC.
Latest Disclosed Ownership35,217 shares
Latest Disclosed Value $ 5,946,390
Williams Jones Wealth Management, LLC. reports 0.84% decrease in ownership of 0JGB / iShares Trust - iShares Biotechnology ETF

On May 5, 2026 - Williams Jones Wealth Management, LLC. filed a 13F-HR form disclosing ownership of 35,217 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $5,946,390 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 35,517 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of -0.84% during the quarter. The current value of the position is $4,615,188 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F ISHARES TR NASDAQ BIOTECH INDX CS 464287556 35,217 -300 -0.84 5,946 -0.80 0.0514
2026-02-13 2025-12-31 13F ISHARES TR NASDAQ BIOTECH INDX CS 464287556 35,517 -468 -1.30 5,994 15.38 0.0677
2025-11-14 2025-09-30 13F ISHARES TR NASDAQ BIOTECH INDX CS 464287556 35,985 -4,100 -10.23 5,195 2.45 0.0594
2025-08-14 2025-06-30 13F ISHARES TR NASDAQ BIOTECH INDX CS 464287556 40,085 -3,023 -7.01 5,071 -8.02 0.0606
2025-05-15 2025-03-31 13F ISHARES TR NASDAQ BIOTECH INDX CS 464287556 43,108 -4,294 -9.06 5,514 -12.03 0.0705
2025-02-14 2024-12-31 13F ISHARES TR NASDAQ BIOTECH INDX CS 464287556 47,402 -7,424 -13.54 6,267 -21.49 0.0756
2024-11-14 2024-09-30 13F ISHARES TR NASDAQ BIOTECH INDX CS 464287556 54,826 -3,160 -5.45 7,983 0.29 0.0936
2024-08-05 2024-06-30 13F ISHARES TR NASDAQ BIOTECH INDX CS 464287556 57,986 -1,243 -2.10 7,959 -2.07 0.0988
2024-05-07 2024-03-31 13F ISHARES TR NASDAQ BIOTECH INDX CS 464287556 59,229 -11,073 -15.75 8,127 -14.90 0.1035
2024-02-14 2023-12-31 13F ISHARES TR NASDAQ BIOTECH INDX CS 464287556 70,302 -29,010 -29.21 9,551 -21.36 0.1337
2023-11-14 2023-09-30 13F ISHARES TR NASDAQ BIOTECH INDX CS 464287556 99,312 -8,118 -7.56 12,145 -10.96 0.1867
2023-08-14 2023-06-30 13F ISHARES TR NASDAQ BIOTECH INDX CS 464287556 107,430 -1,201 -1.11 13,639 -2.79 0.2043
2023-05-15 2023-03-31 13F ISHARES TR NASDAQ BIOTECH INDX CS 464287556 108,631 2,181 2.05 14,031 0.39 0.2198
2023-02-14 2022-12-31 13F ISHARES TR NASDAQ BIOTECH INDX CS 464287556 106,450 -767 -0.72 13,976 11.44 0.2340
2022-11-14 2022-09-30 13F ISHARES TR NASDAQ BIOTECH INDX CS 464287556 107,217 65 0.06 12,540 -0.51 0.2183
2022-08-15 2022-06-30 13F ISHARES TR NASDAQ BIOTECH INDX CS 464287556 107,152 -968 -0.90 12,604 -10.53 0.2040
2022-05-16 2022-03-31 13F ISHARES TR NASDAQ BIOTECH INDX CS 464287556 108,120 865 0.81 14,088 -13.93 0.1963
2022-02-14 2021-12-31 13F ISHARES TR NASDAQ BIOTECH INDX CS 464287556 107,255 465 0.44 16,369 -5.20 0.2045
2021-11-15 2021-09-30 13F ISHARES TR NASDAQ BIOTECH INDX CS 464287556 106,790 -155 -0.14 17,266 -1.35 0.2416
2021-08-16 2021-06-30 13F ISHARES TR NASDAQ BIOTECH INDX CS 464287556 106,945 1,686 1.60 17,502 10.44 0.2448
2021-05-17 2021-03-31 13F ISHARES TR NASDAQ BIOTECH INDX CS 464287556 105,259 1,430 1.38 15,848 0.76 0.2479
2021-02-16 2020-12-31 13F ISHARES TR NASDAQ BIOTECH INDX CS 464287556 103,829 2,802 2.77 15,729 14.98 0.2565
2020-11-13 2020-09-30 13F ISHARES TR NASDAQ BIOTECH INDX CS 464287556 101,027 575 0.57 13,680 -0.37 0.2530
2020-08-14 2020-06-30 13F ISHARES TR NASDAQ BIOTECH INDX CS 464287556 100,452 -162 -0.16 13,731 26.67 0.2812
2020-05-15 2020-03-31 13F ISHARES TR NASDAQ BIOTECH INDX CS 464287556 100,614 -5,822 -5.47 10,840 -15.49 0.2830
2020-02-14 2019-12-31 13F ISHARES TR NASDAQ BIOTECH INDX CS 464287556 106,436 -56,044 -34.49 12,827 -20.66 0.2454
2019-11-14 2019-09-30 13F ISHARES TR NASDAQ BIOTECH INDX CS 464287556 162,480 162,480 16,167 0.3318
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.